SNDL Inc.

SNDL Inc.

SNDL · Nasdaq

SNDL Inc. (SNDL) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for SNDL Inc. in 2026. The next earnings report is expected on November 10, 2026.

Earnings calendar

Next earnings date

10 Nov 2026

In 81 days

EPS estimate

0.00

Revenue estimate

169.4M

Past earnings

28 Jul 2026
EPS actual
-0.02 (-500.7%)
estimate 0.00
Revenue actual
166.2M (-0.1%)
estimate 166.3M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
29 Apr 2026
EPS actual
-0.03 (+11.1%)
estimate -0.03
Revenue actual
140.8M (-6.8%)
estimate 151.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 Mar 2026
EPS actual
0.03 (+166.7%)
estimate 0.01
Revenue actual
183.9M (-2.1%)
estimate 187.9M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
04 Nov 2025
EPS actual
-0.04 (-9,900.0%)
estimate 0.00
Revenue actual
175.3M (+0.5%)
estimate 174.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

SNDL Inc. missed consensus on EPS, with EPS of -$0.0211 versus an estimate of -$0.0035, and met revenue expectations at $166.18 million, about 0.1% below estimates. In the previous report, EPS came in ahead of expectations while revenue fell short of estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

Sector
Healthcare
Industry
Drug manufacturers specialty generic
Country
Canada
Exchange
Nasdaq
CEO
Zachary Ryan George
Employees
2,604
IPO date
01 Aug 2019
ISIN
CA83307B1013
Website
sndlgroup.com

Frequently asked questions

When does SNDL Inc. (SNDL) next report earnings?

SNDL Inc. (SNDL) is scheduled to report earnings on November 10, 2026.

What was SNDL Inc.'s most recent earnings date?

SNDL Inc. (SNDL) last reported earnings on July 28, 2026.

Where is SNDL Inc. stock listed?

SNDL Inc. (SNDL) is listed on Nasdaq.